Microbot Medical Inc. (MBOT) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Hingham, MA, アメリカ. 現CEOは Harel Gadot.
MBOT を有する IPO日 1992-03-25, 20 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $110.74M.
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
